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For the first time, we investigated the relationship between postprandial dysmetabolism and the Peroxidation of Leukocytes Index
Ratio (PLIR), a test thatmeasures the resistance of leukocytes to exogenous oxidative stress and their functional capacity of oxidative
burst upon activation. Following a blind, placebo controlled, randomized, crossover design, ten healthy subjects ingested, in two
different occasions, a high fat and high carbohydrates meal with Snello cookie (HFHCM-S) or with control cookies (HFHCM-
C). Snello cookie, a functional food covered by dark chocolate and containing glucomannan, inulin, fructooligosaccharides, and
Bacillus coagulans strain GanedenBC30, significantly improved postprandial metabolic stress (insulin, glucose, and triglycerides)
and reduced the postprandial increase of uric acid. HFHCM-S improved PLIR of lymphocytes, but not of monocytes and
granulocytes. Both meals increased granulocytes’ count and reduced the lipoperoxidation induced by both exogenous free radicals
and reactive oxygen species (ROS) produced by oxidative burst. Our results suggest that the healthy status of the subjects could
be a limitation of this pilot study for PLIR evaluation on cells that produce ROS by oxidative burst. In conclusion, the relationship
between PLIR and postprandial dysmetabolism requires further investigations.
1. Introduction
Postprandial dysmetabolism has been linked to atherosclero-
sis and inflammation [1]. Therefore, fatty meal consumption
represents a model of acute inflammatory response and has
been applied to study the effect of antioxidant-rich foods,
beverages, or nutritional supplements, but results are scarce
and controversial [2, 3].
Despite the fact that the consumption of high fat and high
carbohydrates meals (HFHCM) has been associated with
oxidative stress and with a decline in antioxidant defences
in plasma, increases in plasma nonenzymatic antioxidant
capacity have been reported following HFHCM [4, 5]. Fur-
thermore, in healthy subjects, both increased [6] and reduced
[7] reactive oxygen species (ROS) generation were observed
in peripheral blood mononuclear cells (PBMC) during the
postprandial period.
In this context, although oxidative stress is involved in
metabolic syndrome, decreases in oxidative burst of neu-
trophils occurred in some conditions, such as hypercholes-
terolaemia [8] and non-insulin-dependent diabetes mellitus
(NIDDM) [9].
Based on the potential protective effects against the onset
of metabolic syndrome [10], functional foods containing
probiotics, prebiotics, and/or polyphenols were placed on the
market. Improvement of metabolic profile, oxidative stress,
and inflammation has been reported also for glucomannan
[11, 12].
de Luis et al. [13] pointed out that one of the problems
of dietetic therapy is the lack of patient adherence and
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Table 1: Macronutrient composition of the two meals.
Kcal Lipids (saturated) Proteins Carbohydrates (sugars)
HFHCM-C (total) 831.4 40.9 (29.6) 6.9 105.7 (63.3)
Panna cotta with caramel (240 g) 647.4 34.3 (27.4) 4.3 77.5 (54.5)
Control cookies (40 g) 184 6.6 (2.2) 2.6 28.2 (8.8)
HFHCM-S (total) 846.4 40.6 (31.2) 6.8 108.8 (65.0)
Panna cotta with caramel (240 g) 647.4 34.3 (27.4) 4.3 77.5 (54.5)
Snello cookie (48 g) 199 6.3 (3.8) 2.5 31.3 (10.5)
C: control cookies; HFHCM: high fat and high carbohydrates meals; S: Snello cookie.
suggested that one possibility to overcome this problem
is to include functional cookies in the diet. In particular,
significant decreases of cholesterol and C reactive protein
were observed in obese patients after the consumption
of an alpha linolenic acid, fructooligosaccharides (FOS),
and inulin-enriched cookie [13]. Improvements of glycemic
control and lipid profile have been reported after con-
sumption of glucomannan-enriched biscuits in subjects with
impaired glucose tolerance, reduced high density lipoprotein
(HDL) cholesterol, elevated serum triglycerides, and moder-
ate hypertension [14].
In this pilot study, we aimed to investigate the relationship
between the improvement of postprandial dysmetabolism by
a functional cookie, covered by dark chocolate and containing
glucomannan, inulin, FOS, and Bacillus coagulans strain
GanedenBC30 [15], and the Peroxidation of Leukocytes Index
Ratio (PLIR), a test that measures the resistance of leukocytes
to exogenous oxidative stress and their functional capacity of
oxidative burst upon activation [16].
2. Methods
2.1. Subjects’ Selection. We recruited 10 healthy subjects who
volunteered in response to advertisements.
Selection of subjects was made according to the following
criteria: being healthy, being aged between 25 and 50 years,
and taking no drugs, supplements, probiotics, or functional
foods. Exclusion criteria include smoking habits and adher-
ence to special diets (vegetarian, vegan).
Systolic Blood Pressure (SBP), Diastolic Blood Pressure
(DBP), and heart rate (HR) were measured. MEDScore [17,
18] was calculated by the MedDietScore Software [19], and
physical activity was calculated according to the “Guidelines
forData Processing andAnalysis of the International Physical
Activity Questionnaire” (IPAQ) [20, 21].
2.2. Study Design and Meals’ Composition. For 2 days prior
to each feeding study, the subjects followed a low antioxidant
and low purine diet (washout), by avoiding fresh fruit and
vegetables with high antioxidants’ content and their products
(juices or soups), tea, cocoa, nuts, coffee and wine, meat,
and fish. Subjects were asked to refrain from exercise 2 days
before the study. Compliance with dietary instructions was
evaluated through dietary records and all subjects ingested
pasta (160 ± 40 g/day), white bread (160 ± 50 g/day), crois-
sant or cookies (50 ± 10 g/day), eggs (1/2 days), cheese
(70 ± 20 g/day), fresh cheese (150 ± 50 g/day), milk (200 ±
50mL/d), only a fruit/day (apple or pear), and less than 60 g/d
of vegetables (zucchini, endive, or fennel).
Following a blind, placebo controlled, randomized,
crossover design, subjects were allocated into Group A (𝑛 =
5) (HFHCM + control cookies) (HFHCM-C) or Group B
(𝑛 = 5) (HFHCM + Snello cookie) (HFHCM-S). Panna
cotta with caramel and control cookies were purchased
from the supermarket. Snello cookie, a functional food
commercially available in Italy, covered by dark chocolate
and containing glucomannan (2.4 g/48 g), inulin (2.3 g/48 g),
FOS (0.2 g/48 g), and Bacillus coagulans strain GanedenBC30
(3 × 106UFC/g), was provided by Nutripharma S.r.l.
After 12 days, subjects followed again 2 days of washout
and 14 days after the first test the groups were crossed over
to the alternative cookies. The macronutrient composition of
the two meals, given as breakfast with 500mL of water, is
depicted in Table 1.
In patients with coronary artery disease (CAD) [22] or
type 2 diabetes (T2D) [23], 2-hour breakfast tests [22, 23]
revealed the improving effects of lipid lowering (fibrate) [22]
or oral hypoglycaemic (mitiglinide) [23] drugs on the phor-
bol ester-activated leukocyte ROS production [22], plasma
malondialdehyde (MDA), oxidized low density lipoproteins
(oxLDL), plasma total radical-trapping antioxidant parame-
ter (TRAP), and inflammatory cytokines [23]. Notwithstand-
ing the above, the Ethics Committee approved a 3-hour test
meal considering that ROS generation by polymorphonu-
clear (PMN) cells reached a peak 3 hours aftermeal in healthy
subjects [6].
On the day of the study, after an overnight fast, venous
blood samples were collected before (𝑇0) and 30 minutes
(𝑇0.5), 2 hours (𝑇2), and 3 hours (𝑇3) after meal.
2.3. ClinicalMarkers. Bloodwas collected in Silicone-Coated
tubes. The serum was stored at −80∘C.
Serum levels of triglycerides (TG), glucose (GLU), and
uric acid (UA) were quantified enzymatically using col-
orimetric kits (Sentinel CH. SpA, Italy). Plasma insulin
was measured with an enzyme-linked immunosorbent assay
(ELISA) kit (Li StarFish S.r.l., Italy).
2.4. PLIR Method. Blood was collected in EDTA tubes.
After red blood cells’ lysis and 4,4-difluoro-5-(4-phenyl-1,
3-butadienyl)-4-bora-3a,4a-diaza-s-indacene-3-undecanoic
acid (C11-BODIPY, Invitrogen, final concentration 1𝜇M)
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staining, leukocytes were treated as previously described
[24] with phorbol 12-myristate 13-acetate (PMA, Sigma, final
concentration 1𝜇g/mL), 2,2󸀠-azobis(2-methylpropionami-
dine) dihydrochloride (AAPH, Sigma, final concentration
10mM), 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic
acid (Trolox, Sigma, final concentration 10𝜇M), PMA
1 𝜇g/mL + Trolox 10 𝜇M, or AAPH 10mM + Trolox 10 𝜇M.
After 30min at 37∘C, cells were stored in ice, to stop reactions,
and rapidly analyzed on an Accuri C6 BD cytometer.
C11-BODIPY, used in the PLIR method, modifies its
fluorescence from red (FL2) to green (FL1) as a result of
oxidation [25]. Treatment with AAPH or PMA changed the
C11-BODIPY fluorescence in a different manner compared to
unstimulated cells (Figure 1(a)), showing that oxidative burst
induced ROS production only in activated cells (Figure 1(b)),
while all cells were sensitive to exogenous (AAPH) ROS
injury (Figure 1(c)). Trolox did not affect neither baseline lev-
els of fluorescence (Figure 1(d)) nor the PMA-induced change
in fluorescence of monocytes and granulocytes (Figure 1(e))
but decreased the AAPH-induced change in fluorescence of
lymphocytes, monocytes, and granulocytes (Figure 1(f)).
Both FL1 and FL2 are higher in monocytes and granu-
locytes compared to lymphocytes in unstimulated samples
(Figure 1(a)). Therefore, in order to normalize for cell incor-
poration of the probe into membrane, data acquired on the
cytometer were exported in FCS format and analyzed by
FCS Express software (De Novo Software) to calculate the
ratio of oxidation of the probe C11-BODIPY (FL1/FL2). This
ratio, being independent of the concentration of the probe,
has been used to calculate PLIR, applying the previously
described [16, 24] formula:
PLIR = (RATIO AAPH × RATIO PMA Trolox)
(RATIO AAPH Trolox × RATIO PMA)
. (1)
PLIR is a functional index that measures the ratio
between the resistance to exogenous (Trolox 𝜇M equivalents
AAPH) and resistance to endogenous (Trolox𝜇Mequivalents
PMA) ROS injury [16]. Although PLIR is independent of the
baseline levels of oxidation, this functional index is sensitive
to the difference between leukocytes isolated from fresh and
stored blood [24].
Also Side Scatter (SS) was recorded and leukocytes’ count
was measured as previously described [26].
2.5. Statistics. Two-Way RepeatedMeasures Analysis of Vari-
ance (Two-Factor Repetition ANOVA), with cookies and
time as within-subject factors, was performed. Student-
Newman-Keuls post hoc analysis (All Pairwise Multiple
Comparison Procedure) was used to isolate differences
between groups.
All statistical evaluations were performed using the Sig-
maStat and Sigmaplot software (Jandel Scientific, Inc.).
3. Results
3.1. Characteristics of Subjects. Based on the exclusion crite-
ria, ten subjects (6 men and 4 women), with a mean age of
36.0 ± 2.9 years and a mean body mass index of 23.3 ± 1.4,
were recruited. Volunteers had a mean homeostasis model
assessment of insulin resistance (HOMA-IR) of 1.6 ± 0.3 and
were normotensive (SBP: 122.9 ± 3.1mmHg, DBP: 75.9 ±
2.1mmHg, and HR: 73 ± 2.5 beats/min).
Subjects had a MEDScore of 35.0/55 ± 1.9 (63.6%
adherence’s level to Mediterranean diet) [19] and a moderate
physical activity (1089 ± 180MET-minutes/week) [21].
3.2. Clinical Markers. Statistical analysis revealed a normal
distribution for all markers (Normality Test Shapiro-Wilk
passed: GLU: 𝑝 > 0.8; INS: 𝑝 > 0.5; TG: 𝑝 > 0.8; UA:
𝑝 > 0.9).
The glucose and insulin time courses reflected the post-
prandial load for healthy people. Both glucose and insulin
levels peaked 30min after meal ingestion (Figures 2(a) and
2(b)).
Although glucose and insulin levels began to decrease
within one hour with both HFHCM-C and HFHCM-S, they
returned to baseline values only with the latter (Figures 2(a)
and 2(b)). In particular, glucose and insulin values were
significantly higher after HFHCM-C compared to HFHCM-
S at 3 hours (HFHCM-S versus HFHCM-C: 𝑝 < 0.01;
Figure 1(a)) and 2 hours (HFHCM-S versus HFHCM-C:
𝑝 < 0.05; Figure 2(b)), respectively. Furthermore, insulin
remained significantly above preingestion values for 3 hours
only after HFHCM-C (𝑝 < 0.05 versus baseline; Figure 2(b)).
With respect to lipid metabolism, both HFHCM-C and
HFHCM-S induced lipaemia at 2 and 3 hours; however, TG
increase was significantly lower after HFHCM-S compared
to HFHCM-C (HFHCM-S versus HFHCM-C: 𝑝 < 0.01
within 2 hours, 𝑝 < 0.001 within 3 hours; Figure 2(c)).
Besides, HFHCM ingestion caused a significant increase in
the endogenous antioxidant UA at 2 hours, but the latter was
lower with HFHCM-S compared to HFHCM-C (within 2
hours: 𝑝 < 0.01, within 3 hours: 𝑝 < 0.05; Figure 2(d)).
Furthermore, only HFHCM-C increased UA at 3 hours (𝑝 <
0.001 versus baseline; Figure 2(d)).
3.3. PLIR, Count, and Scatter of Leukocytes. Statistical analy-
sis revealed a normal distribution for L,M, andGpopulations
(Normality Test Shapiro-Wilk passed: L: 𝑝 > 0.3; M: 𝑝 > 0.2;
G: 𝑝 > 0.3).
HFHCM-S, but not HFHCM-C, significantly decreased
PLIR of lymphocytes at 3 hours (𝑝 < 0.01 versus baseline;
HFHCM-S versus HFHCM-C: 𝑝 < 0.01 within 3 hours;
Figure 3(a)), whereas a nonsignificant decrease was observed
for PLIR of monocytes and granulocytes after HFHCM-S
(Figure 3(a)). In particular, considering the major compo-
nents of PLIR affected by treatment, compared to baseline,
the AAPH-induced (exogenous) oxidation of lymphocytes
appeared significantly lower after HFHCM-S (difference of
means RATIO AAPH versus RATIO UNST: at baseline 0.68,
𝑝 < 0.001, at 3 hours 0.29, 𝑝 < 0.01).
We analyzed also leukocytes’ count and scatter after
meal. The mean count and scatter from lymphocytes and
monocytes remained unchanged after both meals. On the
other hand, there was a postprandial increase in granulocytes’
count with bothmeals (HFHCM-C versus baseline: 𝑝 < 0.01;
HFHCM-S versus baseline: 𝑝 < 0.05; Figure 3(b)). However,
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Figure 1: Typical dot plots of C11-BODIPY red (FL2) and green (FL1, oxidized) fluorescence of lymphocytes (yellow), monocytes (blue), and
granulocytes (green) in unstimulated (UNST) samples (a) and after treatment with phorbol 12-myristate 13-acetate (PMA, (b)), 2,2󸀠-azobis(2-
methylpropionamidine) dihydrochloride (AAPH, (c)), 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox, (d)), PMA+Trolox
(e), or AAPH + Trolox (f).
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Figure 2: Line plots showing the serum levels as means ± standard errors (𝑛 = 10) in plasma glucose (GLU, (a)), insulin (INS, (b)),
triglycerides (TG, (c)), and uric acid (UA, (d)), following high fat and carbohydrates meal ingestion with control (HFHCM-C) or Snello
(HFHCM-S) cookies. Two-Way RepeatedMeasures ANOVA followed by Student-Newman-Keuls post hoc analysis. A: 𝑝 < 0.05; B: 𝑝 < 0.01;
C: 𝑝 < 0.001, single time point versus before meal intake within HFHCM-C; Y: 𝑝 < 0.01; Z: 𝑝 < 0.001, single time point versus before meal
intake within HFHCM-S; ∗𝑝 < 0.05; ∗∗𝑝 < 0.01; ∗∗∗𝑝 < 0.001, HFHCM-S versus HFHCM-C within time.
this increase, after both meals, was accompanied neither by
a reduction of SS in unstimulated samples nor by a different
decrease in SS after PMA-activation (Figure 3(c)).
On the contrary, the increase in the RATIO of fluores-
cence of granulocytes after both PMA and AAPH treatment
versus unstimulated samples appeared lower 3 hours after
both meals (PMA or AAPH versus UNST: HFHCM-C at
baseline: 𝑝 < 0.001; HFHCM-C at 3 hours: 𝑝 < 0.01;
HFHCM-S at baseline: 𝑝 < 0.001; HFHCM-S at 3 hours:
𝑝 < 0.01; Figure 3(d)).
Similarly, nonsignificant effects were observed on mono-
cytes with both meals.
4. Discussion
4.1. Postprandial Dysmetabolism. The functional food Snello
cookie significantly improved postprandial metabolic stress.
In particular, Snello cookie reduced the postprandial TG rise.
Furthermore, glucose and insulin levels returned to baseline
values at 3 hours after HFHCM-S, but not after HFHCM-C.
The effect on postprandial insulin could be due to the con-
tent of glucomannan in Snello cookie. In fact, McCarty [27]
suggested that glucomannan reduces the postprandial insulin
surge. Besides, results of a meta-analysis of randomized
controlled trials pointed out that glucomannan significantly
lowered TG and GLU [11].
On the contrary, a systematic review reported that stud-
ies evaluating the effects of inulin and FOS on glucose
concentration in humans gave contrasting results [28]. On
the other hand, inulin-enriched pasta [29] and breakfast
cereal containing inulin [30] decreased TG. Inulin markedly
increased bifidobacteria count and faecal concentration of
lactate [30]. Lactic acid is involved in the immunomodulating
effect of lactobacilli [31]. Although the prebiotic effects of
inulin-type prebiotics, including FOS and inulin, occur after
long term consumption [32], it has been reported that acute
inulin ingestion increased postprandial serum short-chain
fatty acids and reduced free fatty acids [33, 34].
On the other hand, also the chocolate contained in Snello
cookie could improve postprandial dysmetabolism.Although
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Figure 3: Vertical bars showing the values as means ± standard errors (𝑛 = 10) of PLIR (a), leukocytes count (b), Side Scatter of granulocytes
(c), and RATIO of fluorescence (FL1/FL2) of granulocytes (d), following high fat and carbohydrates meal ingestion with control (HFHCM-C)
or Snello (HFHCM-S) cookies. L: lymphocytes; M: monocytes; G: granulocytes. Two-way Repeated Measures ANOVA followed by Student-
Newman-Keuls post hoc analysis. B: 𝑝 < 0.01, 3 hours (𝑇3) versus before (𝑇0) meal intake within HFHCM-C; X: 𝑝 < 0.05; Y: 𝑝 < 0.01,
3 hours (𝑇3) versus before (𝑇0) meal intake within HFHCM-S; ∗∗𝑝 < 0.01, HFHCM-S versus HFHCM-C within time; ♠𝑝 < 0.01; †𝑝 <
0.001, treatment (PMA: phorbol 12-myristate 13-acetate; AAPH: 2,2󸀠-azobis(2-methylpropionamidine) dihydrochloride) versus unstimulated
(UNST) samples within HFHCM-C; ♣𝑝 < 0.01; ‡𝑝 < 0.001, treatment versus unstimulated (UNST) samples within HFHCM-S.
acute cocoa supplementation showed no clear overall benefit
on postprandial GLU, INS, and TG [35, 36], it has been
reported that an oral supplement of (−)-epicatechin (the
major flavanol contained in chocolate) significantly lowered
GLU and TG 2 hours after meal [37].
Therefore, the overall improvement of postprandial dys-
metabolism induced by Snello cookie could be due to the
synergistic effect of its constituents.
4.2. Postprandial Leukocytes’ Recruitment and Activation.
We observed the previously described [38–41] postprandial
increase of granulocytes’ count at 3 hours. In this context, the
leukocytes’ excursion, after meal, was significantly reduced
with acarbose in patientswithT2Dand subclinical inflamma-
tion (leucocytes> or = 6.2 gigaparticles/L) [42]. Rosiglitazone
reduced the incremental area under the curves for leukocytes,
due to a specific reduction of neutrophils (−39%, 𝑝 < 0.05),
in patients with T2D [43]. On the contrary, rosuvastatin
did not affect baseline leukocytes’ count or the postprandial
neutrophils’ increase in CAD patients [44]. Furthermore,
results of statin withdrawal demonstrated that the expression
of leukocytes’ markers of activation is not affected by the
use of statins [45]. However, the studies that investigated the
effect of glucose on leukocytes’ markers of activation have
shown conflicting results in T2D [45–48]. On the other hand,
postprandial studies reported that leukocytes are activated
by lipids [38, 49, 50]. The expression of leukocytes’ markers
of activation (i.e., CD11b, CD11c) increased on monocytes
or neutrophils after a high fat meal [50, 51]. The extent
of upregulation of the expression of leukocytes’ markers of
activation correlated with TG and was accompanied by an
altered scatter profile [50, 51]. In particular, CD11b expression
on neutrophils was negatively correlated with the mean SS of
neutrophils, reflecting granularity [50].
In our study, the increase in granulocytes’ count was
accompanied neither by a reduction of SS in unstimulated
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samples nor by a different decrease in SS after PMA-
activation. In this context, the fact that, even if white
blood cells’ count increased and intracellular myeloperox-
idase decreased within 2–4 hours after meal, waist-to-hip
ratio influenced the degranulation of PMN must be taken
into account [52]. Besides, recent results showed that only
obese subjects had higher postprandial endotoxemia, the
mechanism of postprandial leukocytes’ activation, despite the
lipaemia increased in both normal-weight and obese men
after meal [53]. Furthermore, postprandial leukocytes’ acti-
vation was highest in patients with T2D and hyperlipidaemia
[45]. Therefore, our pilot study has the major limitation that
subjects were healthy, of normal weight, with a moderate
physical activity and none of them presented risk factors for
CVD.
4.3. PLIR and UA in the Postprandial Phase. Snello cookie
improved PLIR of lymphocytes, but not of monocytes and
granulocytes. To understand this result further considera-
tions should be made.
Although PLIR is a functional index that is independent
of baseline levels of oxidation, measuring the ratio between
the resistance to exogenous and resistance to endogenous
ROS injury [16], this ratio calculation could mask the effect
of foods that inhibit both the exogenous ROS injury and the
oxidative burst. In particular, the calculation of PLIR includes
the PMA-induced oxidation. Lower increases in the RATIO
of fluorescence of granulocytes after both PMA and AAPH
treatment versus unstimulated sampleswere recorded 3 hours
after both HFHCM-C and HFHCM-S compared to baseline.
However, the unchanged mean SS (reflecting granularity)
after meal suggests that the decrease in the RATIO of
fluorescence is more likely due to the antioxidant effect
of UA and cocoa flavanols after HFHCM-C and HFHCM-
S, respectively, rather than an effect on oxidative burst. In
agreement with this hypothesis, Sodre´ et al. [7] reported that
the intracellular ROS in PBMC, assessed by flow cytometry
as the ethidium (ETH) fluorescence, decreased 2 and 4 hours
after meal not only in monocytes but also in lymphocytes,
which do not produce ROS by oxidative burst. On the
contrary, others [6] reported that the release of superoxide
radical by PMN, as measured by chemiluminescence, was
significantly lower when orange juice was added to the
meal than when water or glucose was added to the meal.
However, extracellular free radicals’ measurements, such as
the chemiluminescence assay, are deeply affected by cell
count and viability. Therefore, the postprandial increase of
granulocytes’ count [38–41] could bias these methods.
On the other hand, we observed an increase in UA after
HFHCM-C. This increase could be due to the healthy status
of the subjects. In agreementwith this, increases in TRAP and
UAhave been reported followingHFHCM inhealthy subjects
[4], despite the lower TRAP values after meal in T2D patients
[23].
The increase in UA was lower after HFHCM-S. The
inhibition of UA increase could be due to the cocoa flavanols
contained in Snello cookie. In agreement with this hypothe-
sis, tea flavanols could have UA lowering effect [54, 55] and
fruit-based juice drinks, providing exogenous antioxidants,
prevented the endogenous antioxidant response to HFHCM,
by inhibiting the production of UA [56].
In this context, UA levels could affect PLIR in two
differentways: acting as antioxidant [57] on all leukocytes and
inducing oxidative burst in ROS-producing cells [58]. The
effect of UA depends on its concentration. AAPH-induced
lipid peroxidation, in vitro, was strongly inhibited by UA
at concentration ranging between 50 and 400 𝜇M (0.84–
6.72mg/dL) [57]. The increase in UA after HFHCM-C inges-
tion could justify why HFHCM-C did not change PLIR. In
this context, it has been suggested that in healthy people the
body responds to postprandial stress by inducing endogenous
defenses [4]. In the presence of dietary antioxidants (i.e.,
the chocolate contained in Snello cookie), the resistance
to AAPH-induced oxidation is increased in lymphocytes
despite the reduced UA increase.
On the other hand, although the level at which UA
concentration becomes abnormal is still disputed, rang-
ing between 3.5 and 7.2mg/dL in adult males and post-
menopausal women and between 2.6 and 6.0mg/dL in
premenopausal women [59], a threshold value below the
saturation concentrations (<6mg/dL or <360𝜇mol/L), in
order to prevent monosodium urate (MSU) crystals for-
mation, has been suggested [59, 60]. In fact, in response
to MSU, the neutrophils recruited to sites of inflammation
undergo oxidative burst [58]. In our study, after HFHCM-C,
UA reached the concentration of 5.46 ± 0.13mg/dL, a value
below the threshold value of 6mg/dL [59, 60]. From that, the
healthy status of the subjects could be a limitation of this
study for PLIR evaluation on cells that produce ROS (i.e.,
monocytes and granulocytes).
5. Conclusion
In conclusion, the functional food Snello cookie significantly
improved postprandial metabolic stress and reduced the
postprandial increase of UA.
After HFHCM-S, PLIR was improved on lymphocytes,
but not on monocytes and granulocytes.
The healthy status of the subjects could be a limitation
of this pilot study for PLIR evaluation on cells that produce
ROS (i.e., monocytes and granulocytes). From that, further
studies on subjects who are at risk of cardiovascular diseases
are needed in order to investigate the relationship between
postprandial dysmetabolism and PLIR.
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